BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 21355578)

  • 1. Redox state-dependent interaction of HMGB1 and cisplatin-modified DNA.
    Park S; Lippard SJ
    Biochemistry; 2011 Apr; 50(13):2567-74. PubMed ID: 21355578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nature of full-length HMGB1 binding to cisplatin-modified DNA.
    Jung Y; Lippard SJ
    Biochemistry; 2003 Mar; 42(9):2664-71. PubMed ID: 12614161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox-sensitive structural change in the A-domain of HMGB1 and its implication for the binding to cisplatin modified DNA.
    Wang J; Tochio N; Takeuchi A; Uewaki J; Kobayashi N; Tate S
    Biochem Biophys Res Commun; 2013 Nov; 441(4):701-6. PubMed ID: 24427810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of DNA interstrand cross-link of antitumor cisplatin by HMGB1 protein.
    Kasparkova J; Delalande O; Stros M; Elizondo-Riojas MA; Vojtiskova M; Kozelka J; Brabec V
    Biochemistry; 2003 Feb; 42(5):1234-44. PubMed ID: 12564926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding interaction of HMGB4 with cisplatin-modified DNA.
    Park S; Lippard SJ
    Biochemistry; 2012 Aug; 51(34):6728-37. PubMed ID: 22901013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of tsHMG, a mouse testis-specific HMG-domain protein, to cisplatin-DNA adducts.
    Ohndorf UM; Whitehead JP; Raju NL; Lippard SJ
    Biochemistry; 1997 Dec; 36(48):14807-15. PubMed ID: 9398202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of spectator ligands on the specific recognition of intrastrand platinum-DNA cross-links by high mobility group box and TATA-binding proteins.
    Wei M; Cohen SM; Silverman AP; Lippard SJ
    J Biol Chem; 2001 Oct; 276(42):38774-80. PubMed ID: 11514569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single HMG domain in high-mobility group 1 protein binds to DNAs as small as 20 base pairs containing the major cisplatin adduct.
    Chow CS; Barnes CM; Lippard SJ
    Biochemistry; 1995 Mar; 34(9):2956-64. PubMed ID: 7893709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laser-induced photo-cross-linking of cisplatin-modified DNA to HMG-domain proteins.
    Mikata Y; He Q; Lippard SJ
    Biochemistry; 2001 Jun; 40(25):7533-41. PubMed ID: 11412107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two mutations of basic residues within the N-terminus of HMG-1 B domain with different effects on DNA supercoiling and binding to bent DNA.
    Stros M
    Biochemistry; 2001 Apr; 40(15):4769-79. PubMed ID: 11294645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human testis-determining factor SRY binds to the major DNA adduct of cisplatin and a putative target sequence with comparable affinities.
    Trimmer EE; Zamble DB; Lippard SJ; Essigmann JM
    Biochemistry; 1998 Jan; 37(1):352-62. PubMed ID: 9425057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins.
    Ohndorf UM; Rould MA; He Q; Pabo CO; Lippard SJ
    Nature; 1999 Jun; 399(6737):708-12. PubMed ID: 10385126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding to cisplatin-modified DNA by the Saccharomyces cerevisiae HMGB protein Nhp6A.
    Wong B; Masse JE; Yen YM; Giannikopoulos P; Feigon J; Johnson RC
    Biochemistry; 2002 Apr; 41(17):5404-14. PubMed ID: 11969400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stopped-flow fluorescence studies of HMG-domain protein binding to cisplatin-modified DNA.
    Jamieson ER; Lippard SJ
    Biochemistry; 2000 Jul; 39(29):8426-38. PubMed ID: 10913248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-protein cross-linking by trans-[PtCl(2)(E-iminoether)(2)]. A concept for activation of the trans geometry in platinum antitumor complexes.
    Novakova O; Kasparkova J; Malina J; Natile G; Brabec V
    Nucleic Acids Res; 2003 Nov; 31(22):6450-60. PubMed ID: 14602903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of nuclear proteins that interact with platinum-modified DNA by photoaffinity labeling.
    Zhang CX; Chang PV; Lippard SJ
    J Am Chem Soc; 2004 Jun; 126(21):6536-7. PubMed ID: 15161265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The binding affinity of HMG1 protein to DNA modified by cis-platin and its analogs correlates with their antitumor activity.
    Pasheva EA; Ugrinova I; Spassovska NC; Pashev IG
    Int J Biochem Cell Biol; 2002 Jan; 34(1):87-92. PubMed ID: 11733188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Energetics, conformation, and recognition of DNA duplexes containing a major adduct of an anticancer azolato-bridged dinuclear Pt(II) complex.
    Mlcouskova J; Malina J; Novohradsky V; Kasparkova J; Komeda S; Brabec V
    Biochim Biophys Acta; 2012 Oct; 1820(10):1502-11. PubMed ID: 22683702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of major DNA adducts of enantiomeric cisplatin analogs by HMG box proteins and nucleotide excision repair of these adducts.
    Malina J; Kasparkova J; Natile G; Brabec V
    Chem Biol; 2002 May; 9(5):629-38. PubMed ID: 12031669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermodynamic properties of duplex DNA containing a site-specific d(GpG) intrastrand crosslink formed by an antitumor dinuclear platinum complex.
    Hofr C; Farrell N; Brabec V
    Nucleic Acids Res; 2001 May; 29(10):2034-40. PubMed ID: 11353072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.